Primary Tumor Size
Authors:
- Nanida H. GordonNGNanida H. Gordon
- Robert R. ShenkRSRobert R. Shenk
- Robert M. ZollingerRZRobert M. Zollinger
- Dorothy J. BrumbergDBDorothy J. Brumberg
- Jerry M. ShuckJSJerry M. Shuck
- 1 August 1992
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 127 (8) , 910-916
Abstract
Research from JAMA Surgery — Primary Tumor Size — Relevance to Breast Cancer SurvivalKeywords
This publication has 6 references indexed in Scilit:
- Should all patients with node-negative breast cancer receive adjuvant therapy? Identifying additional subsets of low-risk patients who are highly curable by surgery aloneCancer, 1991
- How To Use Prognostic Factors in Axillary Node-Negative Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 1990
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.Journal of Clinical Oncology, 1989
- Hormone Receptors: An Update and ApplicationSurgical Clinics of North America, 1984
- Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patientsCancer, 1978